Loading clinical trials...
Loading clinical trials...
The proposed investigation will determine the therapeutic potential of aripiprazole augmentation to a stable antidepressant regimen for reducing posttraumatic stress disorder (PTSD) symptoms, cognitive symptoms, psychotic symptoms, and depressive symptoms in veterans with PTSD.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Durham VAMC 508 Fulton Street
Durham, North Carolina, United States
Start Date
March 1, 2007
Primary Completion Date
September 1, 2008
Completion Date
December 1, 2014
Last Updated
March 31, 2015
14
ACTUAL participants
Aripiprazole
DRUG
Placebo
DRUG
Lead Sponsor
Durham VA Medical Center
NCT07010757
NCT07462312
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07447089